.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Chinese Patent Office
McKesson
Argus Health
Fuji
Covington
Colorcon
Medtronic
US Department of Justice
Johnson and Johnson

Generated: September 26, 2017

DrugPatentWatch Database Preview

IBUPROHM Drug Profile

« Back to Dashboard

Which patents cover Ibuprohm, and when can generic versions of Ibuprohm launch?

Ibuprohm is a drug marketed by Ohm Labs and is included in three NDAs.

The generic ingredient in IBUPROHM is ibuprofen; pseudoephedrine hydrochloride. There are sixty-four drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the ibuprofen; pseudoephedrine hydrochloride profile page.

Summary for Tradename: IBUPROHM

Patents:0
Applicants:1
NDAs:3
Bulk Api Vendors: see list109
Patent Applications: see list9,383
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:IBUPROHM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ohm Labs
IBUPROHM
ibuprofen
TABLET;ORAL071214-001Dec 1, 1986OTCNoNo► Subscribe► Subscribe► Subscribe
Ohm Labs
IBUPROHM
ibuprofen
TABLET;ORAL070469-001Aug 29, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Ohm Labs
IBUPROHM COLD AND SINUS
ibuprofen; pseudoephedrine hydrochloride
TABLET;ORAL074567-001Apr 17, 2001OTCNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
UBS
Harvard Business School
Dow
Mallinckrodt
Argus Health
Farmers Insurance
Teva
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot